
What is this cancer?
Multiple myeloma is a cancer of plasma cells in the bone marrow that erodes bone, overproduces abnormal antibody and damages the kidneys. It is usually systemic, but focal lesions often need local control for pain and stability.
Warning signs
- Persistent back or rib pain, especially at night
- Fatigue and repeated infections from anaemia
- Thirst, confusion or kidney problems from high calcium
Diagnosis & staging
Blood and urine electrophoresis with free light chains, bone-marrow biopsy and whole-body low-dose CT or PET-CT define the CRAB criteria and lytic lesions requiring intervention.
Treatment at St. Stamford
Modern anti-myeloma regimens and transplant form the core. Our interventional team treats painful lytic lesions with cementoplasty/ablation, stabilises impending fractures, and uses selective embolization before surgery for vascular plasmacytomas.
Why minimally invasive care
Image-guided ablation and embolization treat the tumour through millimetre-sized punctures, sparing healthy tissue and shortening hospital stay — often an option when surgery, age or prior treatment make open surgery risky.
Every pathway at St. Stamford is planned by a multidisciplinary team — interventional radiologists, medical oncologists and imaging specialists review your scans together. Send your reports before you travel and receive a written pathway in English.
Still have questions?
Reach our care team for personalized guidance on diagnosis, treatment, and insurance.
